LenioBio partners with AffinityAI to accelerate discovery of novel complex proteins through AI-guided design and high-throughput cell-free expression

DÜSSELDORF, Germany, Sept. 3, 2025 /PRNewswire/ — LenioBio GmbH today announced a strategic partnership with AffinityAI, a Danish start-up pioneering AI-driven protein design. This collaboration combines LenioBio’s proprietary cell-free protein expression platform, ALiCE®, with…